Syndecan-4 has also been associated with the metastatic phenotype; analyses of renal cell carcinoma samples and the highly metastatic tumor cell line KP1 have revealed an association between aggressive phenotype and high expression of tissue transglutaminase (TG2) and syndecan-4. This evidence concerns the gene SDC4 and hereditary clear cell renal cell carcinoma.